세계의 분자생물학용 효소, 키트 및 시약 시장 보고서(2025년)
Molecular Biology Enzymes & Kits & Reagents Global Market Report 2025
상품코드 : 1821647
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

분자생물학용 효소, 키트 및 시약 시장의 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 연평균 복합 성장률(CAGR) 16.2%로 433억 7,000만 달러로 성장할 전망입니다. 예측기간의 성장은 자동화 및 고처리량 솔루션, 재생의료에 대한 주력, 조직공학 응용, RNA 간섭 기술에 기인할 것으로 예상됩니다. 예측기간의 주요 동향으로는 생명공학과 생명과학의 성장, PCR기반 기술, 단백질체학의 진보, 신약 응용, 줄기세포 연구 확대, 공동연구, 연구기금 등이 있습니다.

향후 5년간의 예측 성장률 16.2%는 이 시장의 과거 예측에서 0.4% 소폭 감소한 수치입니다. 이러한 성장세 둔화는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세장벽은 독일과 중국에서 공급되는 CRISPR 효소와 역전사(RT)-중합효소연쇄반응(PCR) 마스터믹스의 비용을 상승시킴으로써 미국 내 연구 및 진단에 지장을 초래하고, 생물의학의 혁신을 늦추며, 연구소의 운영 비용을 상승시킬 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

감염증의 유행 증가가 분자생물학용 효소, 키트 및 시약 시장의 성장을 견인할 것으로 예측됩니다. 감염은 박테리아, 곰팡이, 기생충 등을 포함한 유해한 미생물로 인한 질병입니다. 분자생물학용 효소, 키트 및 시약은 이러한 감염성 유기체를 분리하여 특성을 밝히고 환자를 관리하고 치료하는 데 도움이 되는 중요한 역할을 합니다. 예를 들어, 2023년 11월 호주 정부기관인 뉴사우스웨일스 보건부는 수두 감염으로 인한 응급 외래 진찰의 상당한 증가를 보고했으며, 사례 수는 2022년 549례에서 2023년 687례로 증가했고 1년간 25% 증가했습니다. 따라서, 감염증 이환율의 급증이 분자생물학용 효소, 키트 및 시약 시장의 성장을 뒷받침하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Molecular biology enzymes, kits, and reagents are fundamental in the extraction and isolation of DNA or RNA fragments from complex nucleic acid mixtures. They play a crucial role in drug discovery, clinical investigations, and the development of candidate drug molecules. These tools are extensively utilized by pharmaceutical companies for tasks like cloning, RNA and DNA analysis and sequencing, as well as DNA isolation and protein analysis.

The primary products within the domain of molecular biology enzymes, kits, and reagents include enzymes like polymerases, ligases, restriction endonucleases, reverse transcriptase, and others. These kits and reagents find extensive use in molecular diagnostics, genetic disease diagnosis, gene analysis, and molecular fingerprinting. They serve as substances or tools enabling the identification of microorganisms in samples, applied across various fields such as sequencing, cloning, PCR, epigenetics, restriction digestion, and numerous other applications. These tools see utilization in academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic centers, and various other end-user segments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The molecular biology enzymes and kits and reagents market research report is one of a series of new reports from The Business Research Company that provides molecular biology enzymes and kits and reagents market statistics, including molecular biology enzymes and kits and reagents industry global market size, regional shares, competitors with a molecular biology enzymes and kits and reagents market share, detailed molecular biology enzymes and kits and reagents market segments, market trends and opportunities, and any further data you may need to thrive in the molecular biology enzymes and kits and reagents industry. This molecular biology enzymes, kits, and reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The molecular biology enzymes & kits & reagents market size has grown rapidly in recent years. It will grow from $20.87 billion in 2024 to $23.79 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to genomic research advancements, biotechnology industry growth, diagnostic and therapeutic advancements, focus on genomic sequencing, advancements in cloning techniques.

The molecular biology enzymes & kits & reagents market size is expected to see rapid growth in the next few years. It will grow to $43.37 billion in 2029 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to automation and high-throughput solutions, regenerative medicine focus, tissue engineering applications, RNA interference techniques. Major trends in the forecast period include biotechnology and life sciences growth, PCR-based technologies, proteomics advancements, drug discovery applications, stem cell research expansion, collaborations and research funding.

The forecast of 16.2% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. research and diagnostics by increasing the cost of CRISPR enzymes and Reverse Transcription(RT)-Polymerase Chain Reaction(PCR) master mixes sourced from Germany and China, thereby slowing biomedical innovation and elevating laboratory operating costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of infectious diseases is anticipated to drive the growth of the molecular biology enzymes, kits, and reagents market. Infectious diseases are illnesses caused by harmful microorganisms, including bacteria, fungi, parasites, and others. Molecular biology enzymes, kits, and reagents play a crucial role in isolating and characterizing these infectious organisms, aiding in patient control and treatment. For instance, in November 2023, the New South Wales Ministry of Health, an Australian government organization, reported a significant rise in emergency department visits due to chickenpox infections, with cases increasing from 549 in 2022 to 687 in 2023, representing a 25% rise within a year. Therefore, the surge in infectious disease incidence is propelling the growth of the molecular biology enzymes, kits, and reagents market.

The expanding adoption of automation within production processes is anticipated to drive the market for molecular biology enzymes, kits, and reagents. Automation, employing technology such as robotics, streamlines manufacturing operations and bolsters demand for these tools. For instance, as per a report from Manufacturing India in March 2022, India's manufacturing industries are witnessing widespread adoption of automation. Projections suggest that by 2050, around 85-90% of manufacturing firms in India will have embraced automation. This trend is expected to significantly contribute to the growth of the nucleic acid isolation and purification market.

Technological innovation is a prominent trend gaining traction in the molecular biology enzymes, kits, and reagents market. Major players in the industry are developing cutting-edge technologies to expedite disease identification by eliminating bottlenecks in the diagnostic process. Such advancements allow these companies to secure a competitive advantage. For example, in June 2022, Altona Diagnostics, a Germany-based healthcare and diagnostics firm, introduced the RealStar Zoonotic Orthopoxvirus PCR Kit 1.0. This diagnostic tool is specifically designed to detect zoonotic orthopoxviruses, which can be transmitted from animals to humans. Utilizing real-time polymerase chain reaction (PCR) technology, the kit amplifies and identifies specific DNA sequences linked to orthopoxviruses, facilitating quick and accurate detection in both clinical and research environments. It is particularly important for monitoring zoonotic diseases and supporting public health initiatives. The kit comes with all necessary reagents and is compatible with various sample types, making it a valuable resource for laboratories focused on infectious diseases.

Major players in the market for molecular biology enzymes, kits, and reagents prioritize strategic partnerships to advance their objectives. These collaborations involve resource-sharing to foster mutual growth. As seen in February 2023, Ultima Genomics, Inc partnered with New England Biolabs Inc to enhance next-generation sequencing (NGS) procedures for DNA, RNA, and methylation sequencing applications. Such alliances allow companies to combine expertise and resources for technological advancements.

In January 2023, QIAGEN N.V., a manufacturing company based in Germany, acquired Verogen for $150 million. This acquisition aims to strengthen QIAGEN's position as a leader in the rapidly expanding field of human identification and forensics by integrating next-generation sequencing (NGS) technologies. The integration is intended to enhance tools and services used in forensic investigations and missing-person cases. Verogen, a biotechnology company located in the United States, specializes in forensic DNA analysis and molecular diagnostics.

Major companies operating in the molecular biology enzymes & kits & reagents market are Thermo Fisher Scientific Inc., Merck & Co. Inc., Promega Corporation, New England Biolabs Inc., Illumina Inc., Takara Bio USA Holdings Inc., QIAGEN, Agilent Technologies Inc., F Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., LGC Group, Jena Bioscience GmbH, Molecular Biology Resources Inc., Integrated DNA Technologies Inc., Randox Laboratories, ADS Biotec Inc., Goldsite Diagnostics Inc., GE Healthcare, Lucigen Corporation, Bio Basic Inc., Bioo Scientific Corporation, Bioline, Biotechrabbit GmbH, BioWORLD, Epicentre, Hamilton Company, Omega Bio-tek, Sigma-Aldrich, Zymo Research, Abcam plc.

North America was the largest region in the molecular biology enzymes, kits, and reagents market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular biology enzymes & kits & reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the molecular biology enzymes & kits & reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The molecular biology enzymes, kits, and reagents market consists of sales of terminal deoxynucleotidyl transferees, modified bacteriophage T7 DNA polymerase, and T4 DNA polymerase. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Molecular Biology Enzymes & Kits & Reagents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on molecular biology enzymes & kits & reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for molecular biology enzymes & kits & reagents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The molecular biology enzymes & kits & reagents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Molecular Biology Enzymes & Kits & Reagents Market Characteristics

3. Molecular Biology Enzymes & Kits & Reagents Market Trends And Strategies

4. Molecular Biology Enzymes & Kits & Reagents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Molecular Biology Enzymes & Kits & Reagents Growth Analysis And Strategic Analysis Framework

6. Molecular Biology Enzymes & Kits & Reagents Market Segmentation

7. Molecular Biology Enzymes & Kits & Reagents Market Regional And Country Analysis

8. Asia-Pacific Molecular Biology Enzymes & Kits & Reagents Market

9. China Molecular Biology Enzymes & Kits & Reagents Market

10. India Molecular Biology Enzymes & Kits & Reagents Market

11. Japan Molecular Biology Enzymes & Kits & Reagents Market

12. Australia Molecular Biology Enzymes & Kits & Reagents Market

13. Indonesia Molecular Biology Enzymes & Kits & Reagents Market

14. South Korea Molecular Biology Enzymes & Kits & Reagents Market

15. Western Europe Molecular Biology Enzymes & Kits & Reagents Market

16. UK Molecular Biology Enzymes & Kits & Reagents Market

17. Germany Molecular Biology Enzymes & Kits & Reagents Market

18. France Molecular Biology Enzymes & Kits & Reagents Market

19. Italy Molecular Biology Enzymes & Kits & Reagents Market

20. Spain Molecular Biology Enzymes & Kits & Reagents Market

21. Eastern Europe Molecular Biology Enzymes & Kits & Reagents Market

22. Russia Molecular Biology Enzymes & Kits & Reagents Market

23. North America Molecular Biology Enzymes & Kits & Reagents Market

24. USA Molecular Biology Enzymes & Kits & Reagents Market

25. Canada Molecular Biology Enzymes & Kits & Reagents Market

26. South America Molecular Biology Enzymes & Kits & Reagents Market

27. Brazil Molecular Biology Enzymes & Kits & Reagents Market

28. Middle East Molecular Biology Enzymes & Kits & Reagents Market

29. Africa Molecular Biology Enzymes & Kits & Reagents Market

30. Molecular Biology Enzymes & Kits & Reagents Market Competitive Landscape And Company Profiles

31. Molecular Biology Enzymes & Kits & Reagents Market Other Major And Innovative Companies

32. Global Molecular Biology Enzymes & Kits & Reagents Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Molecular Biology Enzymes & Kits & Reagents Market

34. Recent Developments In The Molecular Biology Enzymes & Kits & Reagents Market

35. Molecular Biology Enzymes & Kits & Reagents Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기